Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA3Z0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,075
Award facts
- Contract value 100% obligated
- $16,074.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,074.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract was awarded on January 28, 2026, with an ultimate completion date of January 29, 2026, and involves no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the corporate headquarters for AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3). This delivery order is issued under the parent company Cencora, Inc. (UEI: NWEGNLYTBDW4, doing business as AmerisourceBergen), which holds a substantial indefinite delivery contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This award represents a task order under the DLA's broader pharmaceutical supply chain vehicle, which provides military healthcare systems and federal medical institutions with essential prescription medications and medical supplies. AmerisourceBergen's selection reflects the company's established capability to meet federal procurement requirements through open competition and deliver critical pharmaceutical commodities to support military treatment facilities and veterans' healthcare programs. The firm fixed-price structure and rapid completion timeline indicate this is a time-sensitive fulfillment of a specific pharmaceutical need within the Defense Health Agency's medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FA3Z0?
SPE2DR26FA3Z0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FA3Z0 worth?
The government has obligated $16,075 on SPE2DR26FA3Z0.
Is contract SPE2DR26FA3Z0 an order under another contract?
Yes. SPE2DR26FA3Z0 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA3Z0 competed?
The extent of competition for SPE2DR26FA3Z0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award